| MBS6192860-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) | 0.1 mL | Sign In for Pricing | |
| MBS6192860-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) | 5x 0.1 mL | Sign In for Pricing | |
| MBS630292-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 0.1 mg | Sign In for Pricing | |
| MBS630292-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 5x 0.1 mg | Sign In for Pricing | |
| S6600-93 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) discontinued | 100 µg | Sign In for Pricing | |
| 133882-ML650 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 100 µL | Sign In for Pricing | |
| 035699-ML650 | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (MaxLight 650) discontinued | 100 µL | Sign In for Pricing | |
| 133882-HRP | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 100 µL | Sign In for Pricing | |
| 133882-AP | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) discontinued | 100 µL | Sign In for Pricing | |
| 361244-01 | SSX2 (Protein SSX2, Cancer/testis Antigen 5.2, CT5.2, Synovial Sarcoma, X Breakpoint 2, Tumor Antigen HOM-MEL-40, SSX2A, SSX2B) discontinued | 50 µL | Sign In for Pricing | |
| 361244-02 | SSX2 (Protein SSX2, Cancer/testis Antigen 5.2, CT5.2, Synovial Sarcoma, X Breakpoint 2, Tumor Antigen HOM-MEL-40, SSX2A, SSX2B) discontinued | 100 µL | Sign In for Pricing | |
| 133880 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) | 50 µg | Sign In for Pricing | |
| 133881 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (Not for Export EU) | 100 µL | Sign In for Pricing | |
| 133882 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) | 100 µg | Sign In for Pricing | |
| 170932 | MAP3K8 (TPL2, C-COT, Cancer Osaka Thyroid oncogene, COT, Ewing Sarcoma Transformant, EST, MEKK8, Proto-oncogene c-Cot, Tumor Progression Locus 2, Protein Kinase cot, Tpl-2, ESTF) discontinued | 50 µg | Sign In for Pricing | |
| 170933 | MAP3K8 (TPL2, C-COT, Cancer Osaka thyroid oncogene, COT, Ewing Sarcoma Transformant, EST, MEKK8, Proto-oncogene c-Cot, Tumor Progression Locus 2, Protein Kinase Cot, Tpl-2, ESTF) | 50 µg | Sign In for Pricing | |
| 218589-01 | SSX2, Recombinant, Human, aa1-188, His-Tag (Synovial Sarcoma X Breakpoint 2B, Cancer/Testis Antigen Family 5 Member 2b, CT5.2b) | 20 µg | Sign In for Pricing | |
| 218589-02 | SSX2, Recombinant, Human, aa1-188, His-Tag (Synovial Sarcoma X Breakpoint 2B, Cancer/Testis Antigen Family 5 Member 2b, CT5.2b) | 100 µg | Sign In for Pricing | |
| 133882-ML405 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 405) discontinued | 100 µL | Sign In for Pricing | |
| MBS6235560-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 750) | 0.1 mL | Sign In for Pricing | |
| MBS6235560-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 750) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6224885-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 0.1 mL | Sign In for Pricing | |
| MBS6224885-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 650) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6133996-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) | 0.1 mL | Sign In for Pricing | |
| MBS6133996-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (AP) | 5x 0.1 mL | Sign In for Pricing | |
| 133882-ML490 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (MaxLight 490) | 100 µL | Sign In for Pricing | |
| 035699-ML405 | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (MaxLight 405) discontinued | 100 µL | Sign In for Pricing | |
| 035699-APC | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (APC) discontinued | 200 µL | Sign In for Pricing | |
| 035699-AP | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (AP) discontinued | 200 µL | Sign In for Pricing | |
| 133882-APC | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (APC) | 100 µL | Sign In for Pricing | |
| 035699-HRP | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (Azide free) (HRP) discontinued | 200 µL | Sign In for Pricing | |
| 035699 | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) | 200 µL | Sign In for Pricing | |
| 035699-ML550 | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (MaxLight 550) discontinued | 100 µL | Sign In for Pricing | |
| 035699-ML490 | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (MaxLight 490) discontinued | 100 µL | Sign In for Pricing | |
| 133882-PE | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 100 µL | Sign In for Pricing | |
| 133879 | SSX1 (Protein SSX1, Cancer/Testis Antigen 5.1, CT5.1, Synovial Sarcoma, X Breakpoint 1, MGC150425, MGC5162) | 50 µg | Sign In for Pricing | |
| MBS6155208-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 0.1 mL | Sign In for Pricing | |
| MBS6155208-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (HRP) | 5x 0.1 mL | Sign In for Pricing | |
| MBS6160511-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 0.1 mL | Sign In for Pricing | |
| MBS6160511-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (PE) | 5x 0.1 mL | Sign In for Pricing | |
| MBS620701-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 0.1 mg | Sign In for Pricing | |
| MBS620701-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, HD21, HOM-MEL-40, MGC3884, MGC15364, MGC119055, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 5x 0.1 mg | Sign In for Pricing | |
| MBS6149905-01 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 0.1 mL | Sign In for Pricing | |
| MBS6149905-02 | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 5x 0.1 mL | Sign In for Pricing | |
| BO2081 | Bone disease spectrum (Osteosarcoma, Chondrosarcoma, Myeloma, Ewing's sarcoma, Chordoma, Adamantinoma of long bones, Adamantinoma of mandible, Osteoblastoma, Giant cell tumor, Chondroma, Fibrous dysplasia, Aneurysmal bone cyst)) and cancer ajdacent normal bone tissue array, 104 cases/208 cores-BO2081 | each | Sign In for Pricing | |
| 035699-Biotin | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (Biotin) discontinued | 200 µL | Sign In for Pricing | |
| S6600-93A | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40) | 100 µg | Sign In for Pricing | |
| 035699-FITC | FMR1NB, NT (FMR1NB, Fragile X mental retardation 1 neighbor protein, Cancer/testis antigen 37, Sarcoma antigen NY-SAR-35) (FITC) discontinued | 200 µL | Sign In for Pricing | |
| 133882-Biotin | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (Biotin) | 100 µL | Sign In for Pricing | |
| 133882-FITC | SSX2 (Synovial Sarcoma X Breakpoint 2, Cancer/testis Antigen 5.2, CT5.2, CT5.2a, Protein SSX2, SSX2A, SSX2B, Tumor Antigen HOM-MEL-40, MGC119055, MGC15364, MGC3884) (FITC) | 100 µL | Sign In for Pricing | |